- Home
- IMTE vs PBM Comparison
IMTE vs PBM Comparison
Compare IMTE & PBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMTE
- PBM
- Stock Information
- Founded
- IMTE 2008
- PBM 1994
- Country
- IMTE Malaysia
- PBM Canada
- Employees
- IMTE N/A
- PBM N/A
- Industry
- IMTE Consumer Electronics/Appliances
- PBM
- Sector
- IMTE Consumer Staples
- PBM
- Exchange
- IMTE Nasdaq
- PBM NYSE
- Market Cap
- IMTE 3.5M
- PBM 3.5M
- IPO Year
- IMTE N/A
- PBM N/A
- Fundamental
- Price
- IMTE $1.01
- PBM $2.36
- Analyst Decision
- IMTE
- PBM
- Analyst Count
- IMTE 0
- PBM 0
- Target Price
- IMTE N/A
- PBM N/A
- AVG Volume (30 Days)
- IMTE 125.1K
- PBM 2.0M
- Earning Date
- IMTE 08-12-2025
- PBM 08-12-2025
- Dividend Yield
- IMTE N/A
- PBM N/A
- EPS Growth
- IMTE N/A
- PBM N/A
- EPS
- IMTE N/A
- PBM 41.77
- Revenue
- IMTE $123,337.00
- PBM N/A
- Revenue This Year
- IMTE N/A
- PBM N/A
- Revenue Next Year
- IMTE N/A
- PBM N/A
- P/E Ratio
- IMTE N/A
- PBM $0.12
- Revenue Growth
- IMTE 4.75
- PBM N/A
- 52 Week Low
- IMTE $0.51
- PBM $2.36
- 52 Week High
- IMTE $3.17
- PBM $366.00
- Technical
- Relative Strength Index (RSI)
- IMTE 40.82
- PBM 35.16
- Support Level
- IMTE $1.00
- PBM $5.05
- Resistance Level
- IMTE $1.20
- PBM $9.50
- Average True Range (ATR)
- IMTE 0.15
- PBM 1.90
- MACD
- IMTE -0.03
- PBM -0.42
- Stochastic Oscillator
- IMTE 7.76
- PBM 0.00
About IMTE Integrated Media Technology Limited
Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.
About PBM PSYENCE BIOMEDICAL LTD
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.